<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have previously described a <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> of brief (30 min) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by reperfusion, in which infarction develops gradually, reaching completion more than 3 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, accompanied by morphological, biochemical, and pharmacological evidence of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we tested the hypotheses that delayed administration of a <z:chebi fb="0" ids="48001">protein synthesis inhibitor</z:chebi> would be effective in reducing tissue injury in this slowly evolving ischemic infarction, and that efficacy of this treatment would wane with more prolonged <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced in Long-Evans rats by occlusion of the right middle cerebral artery </plain></SENT>
<SENT sid="3" pm="."><plain>Infarction volume was analyzed using triphenyl tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining, and <z:mp ids='MP_0000002'>morphology</z:mp> was studied using <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin stained sections </plain></SENT>
<SENT sid="4" pm="."><plain>Following 30 min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and reperfusion, the core ischemic region exhibited vacuolization in the neuropil by 36 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and infarction reached full size by 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="27641">Cycloheximide</z:chebi> reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume when given up to 6 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>If the duration of ischemic insult was increased to 90 min, the therapeutic window for delayed <z:chebi fb="0" ids="27641">cycloheximide</z:chebi> was only 30 min </plain></SENT>
<SENT sid="7" pm="."><plain>In permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, <z:chebi fb="0" ids="27641">cycloheximide</z:chebi> was ineffective even when given prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>After mild, but not severe, ischemic insults, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> develops slowly and may be treatable with <z:chebi fb="0" ids="48001">protein synthesis inhibitors</z:chebi>, even when treatment is delayed for up to 6 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>